Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|February 7, 2019
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastomaAntonio Silvani, Irene De Simone, Vittorio Fregoni, et al.
Scientific Reports|June 10, 2018
Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapyLaura Guarnaccia, Stefania Elena Navone, Elena Trombetta, et al.
Journal of Neuropathology and Experimental Neurology|June 28, 2016
MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q DeletionLaura Fontana, Silvia Tabano, Eleonora Bonaparte, et al.
Ebiomedicine|February 10, 2019
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomesIrene Bertolini, Andrea Terrasi, Cristina Martelli, et al.
Journal of Thrombosis and Thrombolysis|April 10, 2021
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective studySerena M Passamonti, Andrea Artoni, Giorgio Carrabba, et al.
International Journal of Molecular Sciences|May 27, 2026
Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130Stefania Elena Navone, Laura Guarnaccia, Massimiliano D Rizzaro, et al.
International Journal of Molecular Sciences|January 11, 2024
Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid RheostatStefania Elena Navone, Laura Guarnaccia, Massimiliano D Rizzaro, et al.
Frontiers in Oncology|March 14, 2022
A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot StudyLeonardo Tariciotti, Valerio M Caccavella, Giorgio Fiore, et al.
Journal of Neurosurgical Sciences|May 12, 2025
Optimal MGMT promoter methylation cut-off to predict better survival in glioblastoma patients undergoing gross-total resectionClaudia Fanizzi, Petra Bintintan-Socaciu, Elena Pirola, et al.
Pageof 6